Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus. (Q51561969)

7 April 2018

title

Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus. (English)

1 reference

7 April 2018

0 references

1 reference

1 reference

Noutsou M

1

1 reference

7 April 2018

Georgopoulos A

series ordinal

2

1 reference

7 April 2018

publication date

1 March 1999

1 reference

7 April 2018

Journal of Diabetes and its Complications

published in

1 reference

7 April 2018

volume

13

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

98-104

1 reference

7 April 2018

Evolving natural history of coronary artery disease in diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Plasma lipid and lipoprotein disorders in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: effects of sex.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Atherogenesis: a postprandial phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Postprandial lipemia, fenofibrate and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

A mathematical model for the determination of total area under glucose tolerance and other metabolic curves

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Simvastatin and lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellS

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2899%2900036-7

7 January 2021

10.1016/S1056-8727(99)00036-7

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018